Page 126 - Cascade_Biocatalysis_Integrating_Stereoselective_and_Environmentally_Friendly_Reactions
P. 126

102  5 Multi-Enzyme Systems and Cascade Reactions Involving Cytochrome P450 Monooxygenases

                    5.2.2
                    Multistep Oxidations Catalyzed by Multiple P450s
                    As mentioned in the previous section, endogenous compounds such as steroids
                    and prostaglandins, as well as exogenous xenobiotic compounds such as drugs or
                    environmental pollutants, undergo multistep degradation processing in the human
                    body. Five human hepatic P450s, namely CYPs 1A2, 2C9, 2C19, 2D6, and 3A4,
                    are involved in almost 95% of the P450-mediated drug metabolism (and in about
                    75% of total drug metabolism) [52, 53]. Among them, CYP3A4 is suggested to
                    metabolize about half of all administered drugs.
                      There are obviously several scenarios for the action mode of hepatic P450s.
                    In many cases, different hepatic P450s belonging either to one or several
                    subfamilies perform various oxygenation reactions at different positions of a single
                    substrate. For instance, the calcium channel blocker verapamil has been found to
                    undergo multiple oxidations by several human P450s from the CYP3A family.
                    As shown by Shen and colleagues [54], CYP3A4, CYP3A5, and CYP3A7 catalyze
                    N-demethylation and N-dealkylation of this compound, yielding the two main
                    products norverapamil (2,8-bis-(3,4-dimethoxyphenyl)-2-isopropyl-6-azaoctanitrile)
                    and   D617   (2-(3,4-dimethoxyphenyl)-5-methylamino-2-isopropylvaleronitrile),
                    respectively (Scheme 5.13).



                                                 CN
                                        O               N          O

                                        O                          O
                                                   Verapamil

                                                     CYPs
                                                  3A4/3A5/3A7





                               CN    H                                   CN
                      O              N           O              O              NH

                      O                          O              O
                               Norverapamil                            D617
                    Scheme 5.13  Metabolism of verapamil by N-dealkylations.

                      Omeprazole, a proton pump inhibitor preventing gastric acid formation, is
                    frequently used in the treatment of acid-related gastrointestinal disorders [55]. In
                    vitro experiments with hepatocytes demonstrated that omeprazole is extensively
                    metabolized to 5-hydroxyomeprazole by CYP2C19 and to omeprazole sulfone by
                    CYP3A4 (Scheme 5.14) [56].
   121   122   123   124   125   126   127   128   129   130   131